Satoshi Kamidani
Academic Appointment
- Assistant Professor of Pediatrics, Division of Pediatric Infectious Diseases, Emory University School of Medicine
Education
Degrees
- MD from Toyama University School of Medicine
- PhD from Toyama University School of Medicine
Research
Publications
-
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.
Clin Infect Dis Volume: 80 Page(s): 223 - 227
02/05/2025 Authors: Fong Y; Dang L; Zhang B; Fintzi J; Chen S; Wang J; Rouphael NG; Branche AR; Diemert DJ; Falsey AR -
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost.
Nat Commun Volume: 16 Page(s): 759
01/17/2025 Authors: Zhang B; Fong Y; Dang L; Fintzi J; Chen S; Wang J; Rouphael NG; Branche AR; Diemert DJ; Falsey AR -
A Phase 1 randomized trial of homologous and heterologous filovirus vaccines with a late booster dose.
NPJ Vaccines Volume: 9 Page(s): 255
12/23/2024 Authors: Rostad CA; Yildirim I; Kao C; Yi J; Kamidani S; Peters E; Stephens K; Gibson T; Hsiao H-M; Singh K -
Relative Contribution of Diagnostic Testing to the Diagnosis of Respiratory Syncytial Virus in Hospitalized Adults in the United States.
J Infect Dis Volume: 230 Page(s): 1342 - 1351
12/16/2024 Authors: Anderson EJ; Tippett A; Begier E; Gibson T; Ess G; Patel V; Taylor M; Reese O; Salazar L; Jadhao S -
A Phase 1, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin) Vaccine in Healthy US Adults.
J Infect Dis Volume: 230 Page(s): 1093 - 1101
11/15/2024 Authors: Kao CM; Rostad CA; Nolan LE; Peters E; Kleinhenz J; Sherman JD; Tippett A; Shih JWK; Yildirim I; Agbakoba V -
Bivalent Omicron BA.4/BA.5 BNT162b2 Vaccine in 6-Month- to <12-Year-Olds.
J Pediatric Infect Dis Soc Volume: 13 Page(s): 421 - 429
08/24/2024 Authors: Sher LD; Boakye-Appiah JK; Hill S; Wasserman E; Xu X; Maldonado Y; Walter EB; Muoz FM; Paulsen GC; Englund JA -
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults.
Clin Infect Dis Volume: 78 Page(s): 1757 - 1768
06/14/2024 Authors: Rostad CA; Atmar RL; Walter EB; Frey S; Meier JL; Sherman AC; Lai L; Tsong R; Kao CM; Raabe V -
Effectiveness of BNT162b2 Vaccine for Preventing COVID-19-Related Hospitalizations: A Test-Negative Case-Control Study.
Vaccines (Basel) Volume: 12
06/13/2024 Authors: Keane A; Tippett A; Taylor EG; Reese O; Salazar L; De Castro K; Choi C; Ciric C; Taylor M; Mitchell A -
Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron-Associated Hospitalization in Children and Adolescents - United States, 2021-2023.
MMWR Morb Mortal Wkly Rep Volume: 73 Page(s): 330 - 338
04/18/2024 Authors: Zambrano LD; Newhams MM; Simeone RM; Payne AB; Wu M; Orzel-Lockwood AO; Halasa NB; Calixte JM; Pannaraj PS; Mongkolrattanothai K -
Influenza Vaccine Effectiveness Pre-pandemic Among Adults Hospitalized With Congestive Heart Failure or Chronic Obstructive Pulmonary Disease and Older Adults.
Clin Infect Dis Volume: 78 Page(s): 1065 - 1072
04/10/2024 Authors: Tippett A; Ess G; Hussaini L; Reese O; Salazar L; Kelly M; Taylor M; Ciric C; Keane A; Cheng A